Home » SUN PHARMA: SWITCHING STRATEGY
SUN PHARMA: SWITCHING STRATEGY
About a year ago, when executives at the Mumbai-based Sun Pharmaceutical Industries started drawing up budgets for the medium term, they were struck by the growth in spend in one cost centre: R&D. From just Rs 20 crore in 2000, the spend on R&D had soared to Rs 140 crore last year, and was projected to grow over 12 per cent annually over the next few years.
TMCnet (http://www.tmcnet.com/usubmit/2006/02/27/1409725.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May